title: Insurers brace for high-cost Sovaldi.
authors.forename: Paul
authors.initials: P
authors.lastname: Demko
authors.forename: Virgil
authors.initials: V
authors.lastname: Dickson
mesh_terms: D016527:Drug Costs; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D007348:Insurance, Health / Q000191:economics*; D008484:Medicaid / Q000191:economics; D000069474:Sofosbuvir; D014481:United States; D014542:Uridine Monophosphate / Q000031:analogs & derivatives* / Q000191:economics / Q000627:therapeutic use
chemical_list: D014542:Uridine Monophosphate; D000069474:Sofosbuvir